⌘K

Login Start Free

Home/Filings/4/0001127602-13-023468

4//SEC Filing

ARRAY BIOPHARMA INC 4

Accession 0001127602-13-023468

CIK 0001100412operating

View on SEC.gov Company Profile

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 7:49 PM ET

Size

8.5 KB

Accession

0001127602-13-023468

Insider Transaction Report

Form 4

Period: 2013-07-24

ARRAY BIOPHARMA INCARRY

DirectorCOO and VP, Business Devel.

Transactions

Exercise/Conversion
Common Stock
2013-07-24$3.75/sh+21,357$80,089→ 1,517,509 total
Tax Payment
Common Stock
2013-07-24$6.07/sh−15,151$91,967→ 1,502,358 total
Exercise/Conversion
Stock Option (Right to Buy)
2013-07-24−21,357→ 0 total
Exercise: $3.75Exp: 2013-08-01→ Common Stock (21,357 underlying)

Holdings

Common Stock
(indirect: By Trust)
119,950

Footnotes (1)

[F1]The option vested in four equal annual installments beginning July 1, 2004.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

ARRAY BIOPHARMA INC

CIK 0001100412

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001100412

Filing Metadata

Form type: 4
Filed: Jul 24, 8:00 PM ET
Accepted: Jul 25, 7:49 PM ET
Size: 8.5 KB

View on SEC.gov